Interpretable Deep Learning with Multi-Scale CT for Predicting Occult Lymph Node Metastasis in Early-Stage NSCLC: A
Zikang Yan1, Xiaojuan Deng2, Jun Dang3,4
1College of Medical Informatics, Chongqing Medical University, Chongqing, 400016, China.
Journal of Imaging Informatics in Medicine
|April 27, 2026
Summary
A new 3D deep learning model accurately predicts occult lymph node metastasis in early non-small cell lung cancer (NSCLC). This AI tool aids in precise staging and treatment decisions for lung cancer patients.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Oncology
Background:
- Accurate prediction of occult lymph node metastasis (OLNM) is vital for early-stage non-small cell lung cancer (NSCLC) treatment planning.
- Current methods for detecting OLNM can be invasive and may not always be accurate.
- Novel, non-invasive methods are needed to improve the preoperative staging of NSCLC.
Purpose of the Study:
- To develop and validate a CT-based three-dimensional (3D) deep learning model for predicting OLNM in early-stage NSCLC.
- To compare the diagnostic performance of the proposed model against other deep learning architectures and experienced radiologists.
- To assess the interpretability of the deep learning model's predictions.
Main Methods:
- A retrospective, multicenter study involving 900 patients with early-stage NSCLC.
- Development of a 3D EfficientNet deep learning model using a primary cohort (n=500) and validation on an external test cohort (n=400).
- Comparison of the model's performance against benchmark deep learning models and four experienced radiologists using AUC metrics.
Main Results:
- The 3D EfficientNet model achieved an AUC of 0.8907 in the internal test set and 0.8721 in the external test cohort.
- The model's performance was statistically superior to other convolutional neural networks and radiologists (P < 0.05).
- Interpretability analysis (Grad-CAM) revealed distinct attention patterns supporting the model's predictions.
Conclusions:
- The developed 3D EfficientNet model shows significant potential as a non-invasive tool for predicting OLNM in early-stage NSCLC.
- This AI-driven approach can enhance the accuracy of preoperative staging for lung cancer.
- The model can assist clinicians in making more precise treatment decisions for NSCLC patients.


